microdosing glp-1 for hashimoto's Does Help with Disease? Evidence and Safety GLP-1 Microdosing: A Medical Perspective

Sjlund, K., Sandn, G., Hkanson, R

The people with HIV were on stable antiretroviral therapy and had not been hospitalized for six months prior to the study

How B12 Deficiency Contributes to Nerve Damage Not enough Vitamin B12 can cause nerve problems

patients with symptomatic decline (poor sleep, body composition changes, reduced energy) may be candidates Patients with body composition goals where GH optimization is clinically relevant: body fat accumulation alongside lean mass reduction that has not responded adequately to lifestyle intervention Individuals seeking sleep quality improvement where GH-axis optimization is part of the clinical picture Athletes or active individuals with recovery requirements where GH-mediated protein synthesis is a clinical priority Patients already in a comprehensive longevity program where GH-axis assessment and optimization is part of the protocol The decision to prescribe Ipamorelin or any GH secretagogue begins with a clinical assessment that includes baseline IGF-1 measurement (the primary marker of GH axis activity), review of the patient's symptom profile, and evaluation of contraindications

The abdomen is an FDA-approved injection site for these medications, offering accessibility and consistent subcutaneous tissue

Julia Promisel Cooper, PhD